MedTrace Logo

Personalized Voice Activated Wellness Assistants for Patients With Heart Failure

NCT03707275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-06-19

No results posted yet for this study

Summary

The Alexa+ Study will compare the use of the Amazon Echo Dot with Alexa voice technology in patients with chronic heart failure to those receiving standard of care heart failure management on changes in health and patient-centered outcomes.

Conditions

Interventions

DEVICE

Alexa+

Patients will receive the Amazon Echo Dot with Alexa voice technology (Alexa+) and will be asked to interact with the device for 3 months. Alexa+ will ask a series of questions. Based on the answers to these questions, it will either contact a study coordinator or will ask patients to take a specific action (such as weighing themselves). Data from this simple intervention will be merged with data extracted from the patient's health record and analyzed for clinical variables and demographics that are most predictive for success in use of these technologies.

OTHER

Standard of Care Arm

This group will receive standard of care (SOC) HF management, which will entail regular follow up from the HF nurse and data from all hospital or clinic visits will be captured from the EHR.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Georgetown-Howard Universities Center for Clinical and Translational Science

    collaborator OTHER

  • ObEN Artificial Intelligence

    collaborator UNKNOWN

  • Medstar Health Research Institute

    lead OTHER

Principal Investigators

  • Nawar M Shara, M.S., PhD · Medstar Health Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-10
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03707275 on ClinicalTrials.gov